DexCom (DXCM) Tops Q3 EPS by 30c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $83.82 -0.07%
EPS Growth %: +9.8%
Financial Fact:
Gross margin: 101.1M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +9.8%
Financial Fact:
Gross margin: 101.1M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q3 EPS of $0.94, $0.30 better than the analyst estimate of $0.64. Revenue for the quarter came in at $500.9 million versus the consensus estimate of $476.75 million.
GUIDANCE:
DexCom sees FY2020 revenue of ~$1.9 billion, versus the consensus of $1.87 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
- ABM Industries (ABM) Reports In-Line Q3 EPS; raises guidance
- Skillsoft (SKIL) Tops Q2 EPS by 14c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
